Colin Cahill Net Worth

The estimated Net Worth of Colin Cahill is at least $3.03 Million dollars as of 17 May 2021. Mr. Cahill owns over 5,793 units of Shockwave Medical stock worth over $2,843,367 and over the last 6 years he sold SWAV stock worth over $0. In addition, he makes $189,170 as Independent Director at Shockwave Medical.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Cahill SWAV stock SEC Form 4 insiders trading

Colin has made over 2 trades of the Shockwave Medical stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 5,793 units of SWAV stock worth $98,481 on 17 May 2021.

The largest trade he's ever made was exercising 5,793 units of Shockwave Medical stock on 17 May 2021 worth over $98,481. On average, Colin trades about 2,317 units every 54 days since 2019. As of 17 May 2021 he still owns at least 8,494 units of Shockwave Medical stock.

You can see the complete history of Mr. Cahill stock trades at the bottom of the page.

Colin Cahill biography

Colin Cahill serves as Independent Director of the Company. Mr. Cahill has been Vice-President of Venrock since 2012 and focuses on Venrock’s public and cross-over biotech fund. Prior to joining Venrock, Mr. Cahill was a co-founder and Chief Development Officer at Simpirica Spine, Inc. (“Simpirica”), a Bay Area medical device company focused on the development and commercialization of devices for spinal stabilization. Mr. Cahill also served as Simpirica’s Chief Executive Officer from 2006 until 2009. Prior to graduate school, Mr. Cahill worked at the Boston Consulting Group as a strategy consultant. Mr. Cahill received a M.B.A. from the Stanford Graduate School of Business and his M.S. in biological sciences from Stanford University. Mr. Cahill received his B.A. and B.S. in biological sciences and economics, respectively, from Stanford University.

What is the salary of Colin Cahill?

As the Independent Director of Shockwave Medical, the total compensation of Colin Cahill at Shockwave Medical is $189,170. There are 6 executives at Shockwave Medical getting paid more, with Douglas Godshall having the highest compensation of $2,208,320.

How old is Colin Cahill?

Colin Cahill is 44, he's been the Independent Director of Shockwave Medical since 2015. There are 14 older and 1 younger executives at Shockwave Medical. The oldest executive at Shockwave Medical Inc. is John M. Adams, 74, who is the Co-Founder and Technical Advisor.

What's Colin Cahill's mailing address?

Colin's mailing address filed with the SEC is C/O SHOCKWAVE MEDICAL, INC., 5403 BETSY ROSS DRIVE, SANTA CLARA, CA, 95054.

Insiders trading at Shockwave Medical

Over the last 6 years, insiders at Shockwave Medical have traded over $488,603,927 worth of Shockwave Medical stock and bought 30,000 units worth $510,000 . The most active insiders traders include James E Deerfield Mgmt L.P...., Antoine Papiernik, and Capital Vii Fcpr Sofinnova. On average, Shockwave Medical executives and independent directors trade stock every 8 days with the average trade being worth of $10,693,924. The most recent stock trade was executed by Trinh Phung on 17 May 2024, trading 19,763 units of SWAV stock currently worth $121,740.

What does Shockwave Medical do?

shockwave medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. inspired by 30-years of safety and efficacy in kidney stone treatment, our lithoplasty® family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. lithoplasty devices use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. an integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. in peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, lithoplasty technology demonstrated safety and consistent procedure success with low procedural complications. the technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatmen

Complete history of Mr. Cahill stock trades at Shockwave Medical

Shockwave Medical executives and stock owners

Shockwave Medical executives and other stock owners filed with the SEC include:

• Douglas Godshall,
  President, Chief Executive Officer, Director
• Daniel Puckett,
  Chief Financial Officer
• Douglas E. Godshall,
  Pres, CEO & Director
• Isaac Zacharias,
  Chief commercial Officer
• Isaac Zacharias,
  Chief Commercial Officer
• Daniel Puckett MBA,
  CFO, Principal Financial Officer & Sec.
• Colin Cahill,
  Independent Director
• F. Thomas Watkins,
  Independent Director
• Antoine Papiernik,
  Independent Director
• Frederic Moll,
  Independent Director
• C. Raymond Larkin,
  Independent Chairman of the board
• Laura Francis,
  Independent Director
• Maria Sainz,
  Director
• Trinh Phung,
  Chief Accounting Officer, Principal Accounting Officer & VP of Fin.
• Robert Fletcher,
  VP of Marketing
• Rob Williamson Jr.,
  VP of Sales
• Hajime Tada J.D.,
  Gen. Counsel & Sec.
• Debbie Kaster,
  Head of Investor Relations
• Mike Maszy,
  VP of Operations
• John M. Adams,
  Co-Founder and Technical Advisor
• Daniel Hawkins,
  Founder and Sr. Advisor
• Sara Toyloy,
  Director
• Capital Vii Fcpr Sofinnova,
  10% owner
• James E Deerfield Mgmt L.P....,
  
• Dan Puckett,
  Chief Financial Officer
• Associates Vii, L.P.Venrock...,
  
• Trinh Phung,
  SVP, Finance
• Kevin J. Ballinger,
  Director
• Renee Gaeta,
  Chief Financial Officer